Correlation of four potential biomarkers of liver fibrosis with liver function and grade of hepatic fibrosis in a neonatal cholestatic rat model

Tang,Ning; Zhang,Yaping; Liu,Zeyu; Ai,Xuemei; Liang,Qinghong

doi:10.3892/mmr.2017.6588

Correlation of four potential biomarkers of liver fibrosis with liver function and grade of hepatic fibrosis in a neonatal cholestatic rat model

Authors:
- Ning Tang
- Yaping Zhang
- Zeyu Liu
- Xuemei Ai
- Qinghong Liang
View Affiliations

Affiliations: Department of Pediatrics, Third Hospital of Hebei Medical University, Shijiazhuang, Hebei 050051, P.R. China
Published online on: May 16, 2017 https://doi.org/10.3892/mmr.2017.6588
Pages: 415-421

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study investigated the correlation between four serum biomarkers of liver fibrosis, liver function and pathological hepatic fibrosis grade in neonatal cholestatic rats. A total of 38 Sprague‑Dawley rats, aged 3 weeks, were randomly assigned to the experimental group (EG), control group (CG) and the blank control group (BCG). EG received intragastric administration of 1% α‑naphthylisothiocyanate, 75 mg/kg, to induce acute cholestasis liver injury, CG and BCG were set as control groups. Blood samples from all groups were collected 48 h following the procedure. The levels of liver function markers, and four biomarkers of liver fibrosis in serum, were measured and sections of liver tissue were stained for pathological analysis. The results of the present study demonstrated that the degree of hepatic fibrosis in EG, in the serum levels or by pathological analysis, was markedly more evident compared with the CG. Several indices of four biomarkers for liver fibrosis in serum were identified and correlated with the levels of liver function markers. The pathological hepatic fibrosis grade was correlated with γ‑glutamyl transferase (γ‑GT) and Hyaluronic acid (HA). Therefore, HA and γ‑GT were positively correlated with the grade of hepatic fibrosis, indicating their efficacy as biomarkers of infantile cholestatic hepatic fibrosis.

View Figures

View References

1	Zolner G and Trauner M: Mechanisms of cholestasis. Clin Liver Dis. 12:1–26. 2008. View Article : Google Scholar : PubMed/NCBI
2	Hines JE, Johnson SJ and Burt AD: In vivo responses of macrophages and perisinusoidal cells to cholestatic injury. Am J Pathol. 142:511–518. 1993.PubMed/NCBI
3	Zhang YP, Yao XX and Zhao X: Interleukin-1 beta up-regulates tissue inhibitor of matrix metalloproteinase-1 mRNA and phosphorylation of c-jun N-terminal kinase and p38 in hepatic stellate cells. World J Gastroenterol. 12:1392–1396. 2006. View Article : Google Scholar : PubMed/NCBI
4	Kossor DC, Meunier PC, Handler JA, Sozio RS and Goldstein RS: Temporal relationship of changes in hepatobiliary function and morphology in rats following alpha-naphthylisothiocyanate (ANIT) administration. Toxico1 Appl Pharmacol. 119:108–114. 1993. View Article : Google Scholar
5	Tang N, Zhang Y, Liu Z, Fu T, Liang Q and Ai X: Correlation analysis between four serum biomarkers of liver fibrosis and liver function in infants with cholestasis. Biomed Rep. 5:107–112. 2016.PubMed/NCBI
6	Gao LN, Yan K, Cui YL, Fan GW and Wang YF: Protective effect of Salvia miltiorrhiza and Carthamus tinctorius extract against lipopolysaccharide-induced liver injury. World J Gastroenterol. 21:9079–9092. 2015. View Article : Google Scholar : PubMed/NCBI
7	Farleigh RM, Knodell RG and Steele NM: Characterization of a hepatic congestion model in the rat: Application of pharmacological studies. Proc Soc Exp Biol Med. 166:134–140. 1981. View Article : Google Scholar : PubMed/NCBI
8	Li GY, Gao HY, Huang J, Lu J, Gu JK and Wang JH: Hepatoprotective effect of Cichorium intybus L., a traditional Uighur medicine, against carbon tetrachloride-induced hepatic fibrosis in rats. World J Gastroenterol. 20:4753–4760. 2014. View Article : Google Scholar : PubMed/NCBI
9	Stasi C and Milani S: Non-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness. World J Gastroenterol. 22:1711–1720. 2016. View Article : Google Scholar : PubMed/NCBI
10	Bedossa P, Dargère D and Paradis V: Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 38:1449–1457. 2003. View Article : Google Scholar : PubMed/NCBI
11	Cadranel JF, Rufat P and Degos F: Practices of liver biopsy in France: Results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology. 32:477–481. 2000. View Article : Google Scholar : PubMed/NCBI
12	Orsler DJ, Ahmed-Choudhury J, Chipman JK, Hammond T and Coleman R: ANIT-induced disruption of biliary function in rat hepatocyte couples. Toxicol Sci. 47:203–210. 1999. View Article : Google Scholar : PubMed/NCBI
13	Golbar HM, Izawa T, Yano R, Ichikawa C, Sawamoto O, Kuwamura M, Lamarre J and Yamate J: Immunohistochemical characterization of macrophages and myofibroblasts in α-Naphthylisothiocyanate (ANIT)-induced bile duct injury and subsequent fibrogenesis in rats. Toxicol Pathol. 39:795–808. 2011. View Article : Google Scholar : PubMed/NCBI
14	Kim SK and Kim YC: Effects of betaine supplementation on hepatic metabolism of sulfur-containing amino acids in mice. J Hepatol. 42:907–913. 2005. View Article : Google Scholar : PubMed/NCBI
15	Li SB, Xu FM, Xue C, Ding XJ, Li YC, QIian LY, Zhang GL and Zeng F: Protective effects of ursodeoxycholic acid on a-naphthylisothi-induced acute liver injury in rats. Chin J Digestion. 32:325–329. 2012.
16	Lee HH, Seo YS, Um SH, Won NH, Yoo H, Jung ES, Kwon YD, Park S, Keum B, Kim YS, et al: Usefulness of non-invasive markers for predicting significant fibrosis in patients with chronic liver disease. J Korean Med Sci. 25:67–74. 2010. View Article : Google Scholar : PubMed/NCBI
17	Lijia S, Aifei T and Ruilong X: The clinical value of serum markers of liver fibrosis in patients with viral hepatitis. Jiangxi J Med Lab Sci. 25:453–454. 2007.
18	El-Shabrawi MH, El Zein Abedin MY, Omar N, Kamal NM, Elmakarem SA, Khattab S, El-Sayed HM, El-Hennawy A and Ali AS: Predictive accuracy of serum hyaluronic acid as a non-invasive marker of fibrosis in a cohort of multi-transfused Egyptian children with β-thalassaemia major. Arab J Gastroenterol. 13:45–48. 2012. View Article : Google Scholar : PubMed/NCBI
19	Nath NC, Rahman MA, Khan MR, Hasan MS, Bhuiyan TM, Hoque MN, Kabir MM, Raha AK and Jahan B: Serum hyaluronic acid as a predictor of fibrosis in chronic hepatitis B and C virus infection. Mymensingh Med J. 20:614–619. 2011.PubMed/NCBI
20	Nobili V, Alisi A, Torre G, De Vito R, Pietrobattista A, Morino G, De Ville De Goyet J, Bedogni G and Pinzani M: Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease. Transl Res. 156:229–234. 2010. View Article : Google Scholar : PubMed/NCBI
21	Teare JP, Sherman D, Greenfield SM, Simpson J, Bray G, Catterall AP, Murray-Lyon IM, Peters TJ, Williams R and Thompson RP: Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis. Lancet. 342:895–898. 1993. View Article : Google Scholar : PubMed/NCBI
22	Fan L and Zhihua H: Significance of serum 5′-Nucleotidase and γ-glutamyltranspeptidase in differential diagnosis for infantile hepafitis syndrome and biliary atresia. J Clin Exper Med. 8:16–17. 2009.
23	Tarantino G, Finelli C, Colao A, Capone D, Tarantino M, Grimaldi E, Chianese D, Gioia S, Pasanisi F, Contaldo F, et al: Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase? J Transl Med. 10:502012. View Article : Google Scholar : PubMed/NCBI
24	Tavian D, Degiorgio D, Roncaglia N, Vergani P, Cameroni I, Colombo R and Coviello DA: A new splicing site mutation of the ABCB4 gene in intrahepatic cholestasis of pregnancy with raised serum gamma-GT. Dig Liver Dis. 41:671–675. 2009. View Article : Google Scholar : PubMed/NCBI
25	Du W, Zhang Y and Zhai W: A study on type I, II and IV collagen product ion in CCL4 induced rat liver fibrosis. Zhonghua Bing Li Xue Za Zhi. 26:74–77. 1997.(In Chinese). PubMed/NCBI